Log in to save to my catalogue

Effectiveness of methylphenidate as augmentation therapy after failure of adjunctive neuromodulation...

Effectiveness of methylphenidate as augmentation therapy after failure of adjunctive neuromodulation...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3979787

Effectiveness of methylphenidate as augmentation therapy after failure of adjunctive neuromodulation for patients with treatment-refractory bipolar depression: a case report

About this item

Full title

Effectiveness of methylphenidate as augmentation therapy after failure of adjunctive neuromodulation for patients with treatment-refractory bipolar depression: a case report

Publisher

New Zealand: Dove Medical Press Limited

Journal title

Neuropsychiatric disease and treatment, 2014-01, Vol.10, p.559-562

Language

English

Formats

Publication information

Publisher

New Zealand: Dove Medical Press Limited

More information

Scope and Contents

Contents

Adjunctive use of methylphenidate, a central stimulant, has been considered as a potential therapeutic choice for patients with refractory unipolar, geriatric, or bipolar depression, and depression secondary to medical illness. We present a case of bipolar depression in which the patient responded significantly to augmentation with methylphenidate,...

Alternative Titles

Full title

Effectiveness of methylphenidate as augmentation therapy after failure of adjunctive neuromodulation for patients with treatment-refractory bipolar depression: a case report

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3979787

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3979787

Other Identifiers

ISSN

1176-6328

E-ISSN

1176-6328,1178-2021

DOI

10.2147/NDT.S58644

How to access this item